Pricing Log in Create free account
Saturday 17 October 2026 Export VTRS’s income statement to Excel — free account

Viatris Inc.

VTRS Healthcare Drug Manufacturers Specialty & Generic

Viatris Inc.’s revenue for fiscal 2025 (year ended December 2025) was $14.3 billion, down 2.98% from fiscal 2024. In the quarter to June 2026, revenue grew 4.88%, EPS fell 2,464.1%, free cash flow grew 101.1% and total debt fell 18.1%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for five consecutive years.

18.66 0.44 +2.41%
Market cap
$20.9B
P/E
0.0×
Fwd P/E
61.1×
Dividend yield
2.57%
F-score
4/9
Altman Z
0.61
Beneish M
−3.29
Dividend safety
37/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Viatris Inc. (VTRS) Current ratio

Alert me on Current ratio

Viatris Inc.'s current ratio at the end of the quarter to 30 June 2026 was 1.6×, up 0.2× from fiscal 2025 (1.4×). Over the past ten years it has ranged from 1.1× (fiscal 2021) to 1.7× (fiscal 2023); the current reading is higher than 45% of that period. That is below the Drug Manufacturers Specialty & Generic industry median of 2.3× and below the Healthcare sector median of 3.0×.

Current ratio, annual

Embed this chart

Annual newest first

Period Current ratio Change
FY2025 1.4× (16.24%)
FY2024 1.6× (1.26%)
FY2023 1.7× 5.83%
FY2022 1.6× 42.93%
FY2021 1.1× (9.46%)
FY2020 1.2× 0.40%
FY2019 1.2× (12.58%)
FY2018 1.4× 22.86%
FY2017 1.1× (24.30%)
FY2016 1.5× (4.95%)

Quarterly newest first

Period Current ratio Change
Jun 2026 1.6× (1.15%)
Mar 2026 1.6× 16.17%
Dec 2025 1.4× 2.12%
Sep 2025 1.4× (1.39%)
42 more quarters

Against its own ten years

Low 1.1× High 1.7×
Ten-year median 1.4×
Current reading's percentile 45

Current ratio against peers

Company Current ratio
UTHR United Therapeutics Corporation compare 5.7×
ZTS Zoetis Inc. compare 3.1×
ELAN Elanco Animal Health Incorporated compare 2.1×
RDY Dr. Reddy's Laboratories Ltd compare 1.9×
NBIX Neurocrine Biosciences, Inc. compare 1.9×
VTRS Viatris Inc. 1.6×
TAK Takeda Pharmaceutical Co. compare 1.1×
TEVA Teva Pharmaceutical Industries Ltd. compare 0.9×
HLN Haleon PLC Sponsored ADR compare 0.7×
Drug Manufacturers Specialty & Generic industry median 2.3×
Healthcare sector median 3.0×
Market median 1.6×

What Current ratio is

Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.

Current Assets (Total) ÷ Current Liabilities (Total)

The full definition of Current ratio →

More on VTRS